Fabesetron (FK1052) is a novel, potent and orally bioactive 5-HT3 receptor antagonist with 5-HT4 receptor antagonistic activity. It has the potential to be used in treating acute and delayed emesis induced by cancer chemotherapy.

纯度：≥98%

CAS：129300-27-2